Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.

Under the ongoing collaboration Remedy Cell’s personnel, along with Pluri’s Contract Development and Manufacturing Organization (“CDMO”) division (PluriCDMO™), have successfully completed the full ...

Gene editing platforms like CRISPR-Cas9 that rely on nuclease activity introduce effective modifications, however, they arise from double strand DNA breaks (DSBs) introduced by the nuclease that can ...

Regenerative medicine combines tissue engineering and cell therapies to repair or replace damaged human tissues and organs. Key applications include treating osteoarthritis with mesenchymal stem cells ...

Cardiovascular Reparative Medicine and Tissue Engineering (CRMTE) aims to develop future technologies and therapeutic strategies that will serve as treatment for cardiovascular disease. CRMTE includes ...

Enables in vivo delivery of LEU011 harnessing the VivoCell PlatformTMLONDON and CHICAGO, Dec. 15, 2025 /PRNewswire/ -- Leucid Bio ("Leucid" or the "Company"), a privately-held biotechnology ...

Modern biology runs on precision, yet so much of the daily lab workflow remains stubbornly manual. Even today, one of the ...

Engineers have turned one of nature’s most reviled body parts into a precision tool, using the hollow feeding tubes of dead ...

As the demand for renewable energy grows, scientists are developing new types of solar cells that are both highly efficient ...

EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work ...